Polio outbreaks: a tale of torment

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age.

Vaccine·2011

Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old.

Vaccine·2009

Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization.

Pediatrics·1998

Influenza pandemic preparedness plan for the United States.

The Journal of infectious diseases·1997

Syncope after immunization.

Archives of pediatrics & adolescent medicine·1997

Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.

The Journal of infectious diseases·1997

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Health-Related Quality of Life Following Botulinum Toxin for Retrograde Cricopharyngeus Dysfunction.

The Laryngoscope·2026

Occurrence of Dysphagia in Patients Admitted to a Department of Pulmonary Medicine.

Clinical nutrition ESPEN·2026

Effects of intrinsic capacity on health-related outcomes are moderated by frailty status among community-dwelling older adults.

The journal of nutrition, health & aging·2026

Outcomes of neuromuscular retraining and adjunctive electrical stimulation in Bell's palsy: a single-centre observational cohort study.

Acta neurologica Belgica·2026

The Incidence of Sensorineural Hearing Loss Diagnoses in People with and without Parkinson's Disease.

Movement disorders clinical practice·2026

Does near-vision correction improve digital data entry accuracy? A simulated within-subject crossover study among community health workers in Malawi.

BMJ public health·2026

Related Experiment Videos

Polio outbreaks: a tale of torment

Related Concept Videos

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age.

Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old.

Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization.

Influenza pandemic preparedness plan for the United States.

Syncope after immunization.

Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Health-Related Quality of Life Following Botulinum Toxin for Retrograde Cricopharyngeus Dysfunction.

Occurrence of Dysphagia in Patients Admitted to a Department of Pulmonary Medicine.

Effects of intrinsic capacity on health-related outcomes are moderated by frailty status among community-dwelling older adults.

Outcomes of neuromuscular retraining and adjunctive electrical stimulation in Bell's palsy: a single-centre observational cohort study.

The Incidence of Sensorineural Hearing Loss Diagnoses in People with and without Parkinson's Disease.

Does near-vision correction improve digital data entry accuracy? A simulated within-subject crossover study among community health workers in Malawi.

Related Experiment Videos

Polio outbreaks: a tale of torment

Related Concept Videos

Related Articles